Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.

Zhang X, Tworoger SS, Eliassen AH, Hankinson SE.

Breast Cancer Res Treat. 2013 Feb;137(3):883-92. doi: 10.1007/s10549-012-2391-z. Epub 2013 Jan 3.

PMID:
23283524
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
[PubMed - indexed for MEDLINE]
Free Article
3.

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID:
17018787
[PubMed - indexed for MEDLINE]
Free Article
4.

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.

J Natl Cancer Inst. 2005 May 18;97(10):755-65.

PMID:
15900045
[PubMed - indexed for MEDLINE]
Free Article
5.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
[PubMed - indexed for MEDLINE]
Free Article
6.

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.

Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G, Schunemann HJ, Menard S, Berrino F, Muti P.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):169-76. doi: 10.1158/1055-9965.EPI-08-0808.

PMID:
19124495
[PubMed - indexed for MEDLINE]
Free Article
7.

Serum sex hormone levels after menopause and subsequent breast cancer.

Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G.

J Natl Cancer Inst. 1996 Mar 6;88(5):291-6.

PMID:
8614008
[PubMed - indexed for MEDLINE]
Free Article
8.

Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.

James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel-Chapelon F, Chang-Claude J, Vrieling A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodríguez L, Buckland G, Sánchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita B, Ros MM, van Gils CH, Peeters PH, Khaw KT, Wareham N, Key TJ, Allen NE, Romieu I, Siddiq A, Cox D, Riboli E, Kaaks R.

Cancer Prev Res (Phila). 2011 Oct;4(10):1626-35. doi: 10.1158/1940-6207.CAPR-11-0090. Epub 2011 Aug 2.

PMID:
21813404
[PubMed - indexed for MEDLINE]
9.

Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.

Tamimi RM, Byrne C, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. Epub 2007 Jul 24.

PMID:
17652278
[PubMed - indexed for MEDLINE]
Free Article
10.

Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, Vittinghoff E, Lee JS, Lacroix AZ, Cauley JA, Jackson R, Grady D, Lane DS, Phillips L, Simon MS, Cummings SR.

J Natl Cancer Inst. 2013 Oct 2;105(19):1496-503. doi: 10.1093/jnci/djt243. Epub 2013 Sep 16.

PMID:
24041978
[PubMed - indexed for MEDLINE]
11.

Prospective study of sex hormone levels and risk of prostate cancer.

Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.

J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26.

PMID:
8757191
[PubMed - indexed for MEDLINE]
Free Article
12.

Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.

Woolcott CG, Shvetsov YB, Stanczyk FZ, Wilkens LR, White KK, Caberto C, Henderson BE, Le Marchand L, Kolonel LN, Goodman MT.

Endocr Relat Cancer. 2010 Feb 18;17(1):125-34. doi: 10.1677/ERC-09-0211. Print 2010 Mar.

PMID:
19903744
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.

Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, Pasternack BS, Toniolo P.

Am J Epidemiol. 1997 Jun 1;145(11):1030-8.

PMID:
9169912
[PubMed - indexed for MEDLINE]
Free Article
14.

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE.

J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9.

PMID:
9731736
[PubMed - indexed for MEDLINE]
Free Article
15.

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.

Fourkala EO, Zaikin A, Burnell M, Gentry-Maharaj A, Ford J, Gunu R, Soromani C, Hasenbrink G, Jacobs I, Dawnay A, Widschwendter M, Lichtenberg-Fraté H, Menon U.

Endocr Relat Cancer. 2012 Apr 10;19(2):137-47. doi: 10.1530/ERC-11-0310. Print 2012 Apr.

PMID:
22199143
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.

Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS, Lee JS.

J Natl Cancer Inst. 2011 Apr 6;103(7):562-70. doi: 10.1093/jnci/djr031. Epub 2011 Feb 17.

PMID:
21330633
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.

Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):492-502. doi: 10.1158/1055-9965.EPI-09-0532. Epub 2010 Jan 19.

PMID:
20086116
[PubMed - indexed for MEDLINE]
Free Article
18.

Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).

Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P.

Cancer Causes Control. 2003 Sep;14(7):599-607.

PMID:
14575357
[PubMed - indexed for MEDLINE]
19.

Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.

Falk RT, Gentzschein E, Stanczyk FZ, Garcia-Closas M, Figueroa JD, Ioffe OB, Lissowska J, Brinton LA, Sherman ME.

Breast Cancer Res Treat. 2012 Jan;131(1):287-94. doi: 10.1007/s10549-011-1734-5. Epub 2011 Aug 26.

PMID:
21870130
[PubMed - indexed for MEDLINE]
20.

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Key T, Appleby P, Barnes I, Reeves G; Endogenous Hormones and Breast Cancer Collaborative Group.

J Natl Cancer Inst. 2002 Apr 17;94(8):606-16.

PMID:
11959894
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk